Intelligence Β· Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs Β· EMA approved Β· by data quality Β· Page 6 of 39

  1. ivacaftor

    KALYDECO Vertex Pharmaceuticals (Australia) Pty.

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    R07AX32
  2. ivosidenib

    TIBSOVO Servier Laboratories (Aust.) Pty.

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    L01XM02
  3. ixazomib

    NINLARO Takeda

    EMA: approved Β· NMPA: clinical trials

    L01XG03
  4. ketoconazole

    KETOCONAZOLE AID-SCFM S.A.

    TOPICAL FDA: approved Β· EMA: approved

    J02AB02
  5. lacosamide

    LACOMED Alphapharm Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    N03AX18
  6. lamivudine

    3TC ViiV Healthcare Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    J05AF05
  7. lanadelumab

    TAKHZYRO Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    B06AC05
  8. lebrikizumab

    EBGLYSS S.A.

    EMA: approved Β· PMDA: approved

    D11AH10
  9. leflunomide

    APO-LEFLUNOMIDE Alphapharm Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    L04AK01
  10. lenalidomide

    LENALIDE Bristol-Myers Squibb Australia Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L04AX07
  11. levetiracetam

    APO-LEVETIRACETAM Alphapharm Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    N03AX14
  12. levodopa

    CORBILTA (PREVIOUSLY LEVODOPA/CARBIDOPA/ENTACAPONE SANDOZ) Amneal Pharma Europe Ltd

    ORAL FDA: approved Β· EMA: approved

    N04BA02
  13. levofloxacin

    QUINSAIR Teva Pharma GmbH

    OPHTHALMIC FDA: approved Β· EMA: approved

    J01MA12
  14. lidocaine

    LIGNOCAINE INJECTION (BRIDGEWEST) Lacuna Pharma Pty Ltd

    TOPICAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    N01BB20
  15. linagliptin

    TRAJENTA Boehringer Ingelheim Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved

    A10BD11
  16. linvoseltamab

    LYNOZYFIC Regeneron UK Limited

    EMA: approved

    L01FX
  17. lipegfilgrastim

    LONQUEX Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    L03AA14
  18. liraglutide

    SAXENDA Teva Pharma GmbH

    SUBCUTANEOUS FDA: approved Β· EMA: approved Β· PMDA: approved Β· NMPA: clinical trials

    A10BJ02
  19. lumacaftor

    ORKAMBI Vertex Pharmaceuticals (Australia) Pty.

    EMA: approved

    R07AX30
  20. lumasiran

    OXLUMO Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    A16AX18
  21. mannitol

    BRONCHITOL Milestone Pharmaceuticals

    IRRIGATION FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    R05CB16
  22. maralixibat chloride

    LIVMARLI Mirum Pharmaceuticals International B.V.

    ORAL FDA: approved Β· EMA: approved Β· PMDA: approved

    A05AX04
  23. maribavir

    LIVTENCITY Lacuna Pharma Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    J05AX10
  24. mecasermin

    INCRELEX Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    H01AC03

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.